跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
EXELON PATCH 10 rivastigmine 9.5mg/24 hours transdermal drug delivery system sachet
Approved
STANDARD
EXELON PATCH 10 rivastigmine 9.5mg/24 hours transdermal drug delivery system sachet
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
70285e20dceca249
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
70285e20dceca249
Product Name
EXELON PATCH 10 rivastigmine 9.5mg/24 hours transdermal drug delivery system sachet
Artg Id
133428
Artg Name
EXELON PATCH 10 rivastigmine 9.5mg/24 hours transdermal drug delivery system sachet
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2008-03-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/875fc06f27d98a5cc3bd786ef44487c2.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/de083135bedb1c1df5dbe2598e212284.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
70285e20dceca249
Type
Standard
Back to TGA Approvals
EXELON PATCH 10 rivastigmine 9.5mg/24 hours transdermal drug delivery system sachet - TGA Drug Approval Details